Popular Articles

Secretary Sebelius Releases New Success Story Report: Community-Based Prevention Program In Nebraska Helps Prevent Heart Disease And Stroke
HHS Secretary Kathleen Sebelius today released the second in a series of health care success story reports that document innovative programs and initiatives that can serve as models for a reformed American health care system. Today"s report highlights the Nebraska WISEWOMAN program. WISEWOMAN is a community intervention program funded by the Centers for Disease Control and Prevention that helps prevent heart disease and stroke by providing screenings and counseling for low-income women. The report is available at http://www.healthreform.gov.
generic viagra online
Results From A European Caregiver Survey Highlight The Impact Of Attention Deficit Hyperactivity Disorder (ADHD) On The Child And The Family
Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, today announced results of a European survey that found a child"s Attention Deficit Hyperactivity Disorder (ADHD) symptoms at school were a key concern for parents, yet outside of school their child"s ADHD also had significant impact on parents" personal time.1 The survey also revealed key findings surrounding parents" role in assessment and treatment for their child.1 Additionally, the survey suggested that informational needs may not be met adequately for these children with ADHD and their families.1 Conducted in partnership with ADHD advocacy groups in four EU countries, the survey analysed parental impressions surrounding the impact of ADHD on their child, themselves and their family, as well as their child"s ADHD treatment plan.
News of the day
Sanofi-aventis And Regeneron Announce Results From Phase 2 Study With Aflibercept (VEGF Trap) In Advanced Ovarian Cancer
Sanofi Aventis (Euronext: SAN and NYSE: SNY) and Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN) announced that advanced ovarian cancer patients with recurrent symptomatic malignant ascites (SMA) receiving aflibercept (VEGF Trap) in a randomized, placebo-controlled Phase 2 study experienced a statistically significant improvement in the primary study endpoint, mean time to first repeat paracentesis (removal of fluid from the abdominal cavity), versus placebo control. Symptomatic malignant ascites is an abnormal build-up of fluid in the abdominal cavity in patients with advanced cancer.
Public Health

Textbook Chronicling Four Decades Of Alzheimer's Research

Two of the world"s leading Alzheimer"s researchers have co-edited a book critically synthesizing the major new developments in the diagnosis and treatment of Alzheimer"s disease. Building upon a 2007 Alzheimer"s disease conference held in Chile, George Perry, dean of the College of Sciences at The University of Texas at San Antonio (UTSA) and Ricardo B. Maccioni, neurology professor at The University of Chile Medical School have edited "Current Hypotheses and Research Milestones in Alzheimer"s Disease," a 254-page text written by academics and medical doctors. The book focuses on the most promising hypotheses that illuminate the path to more effective treatment. Highlights include: * new information about the biology of amyloid-Ãÿ, the main component in the amyloid plaques found in the brains of Alzheimer"s disease patients, and where the field has concentrated its efforts for nearly 20 years * the Tau Hypothesis, which suggests Alzheimer"s disease is caused by abnormal chemical changes to tau proteins disrupting the normal cell biology of neurons * the Oxidative Stress Hypothesis, which indicates neurons degenerate and die because the brains of patients with Alzheimer"s disease have a disrupted oxidative metabolism leading to decreased neuronal energy supply and increased oxidative damage * neuroimmunological hypotheses linking Alzheimer"s disease to the chronic low level inflammation thought to underlie arthritis, coronary disease and other age-related conditions * the development of biomarkers for early diagnosis * new horizons for the development of anti-dementia drugs "Alzheimer"s disease is the leading cause of dementia in senior citizens," said Perry, also a professor in UTSA"s Department of Biology. "While the scientific community hasn"t been able to pinpoint the cause of the disease, researchers around the world are advancing what we know about the disease and how we might be able to treat it in the future." Perry, ranked one of the top ten Alzheimer"s disease researchers in the world in 2009, joined UTSA in 2006 from Case Western Reserve University, where he was a professor of pathology and neurosciences and the chair of Case Western Reserve"s Department of Pathology. A prolific researcher, Perry is the second-most published Alzheimer"s disease researcher, with 516 publications to his credit. He serves as president of the American Association of Neuropathologists and is on the editorial boards of more than 70 journals including the American Journal of Pathology and the Journal of Biological Chemistry. He also is co-editor-in-chief of the Journal of Alzheimer"s Disease, the leading journal for Alzheimer research. Christi Fish University of Texas at San Antonio


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):